Use of L-carnitine in the prevention and treatment of hearing loss
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 3, 2005
app pub date -
Jul 26, 2004
filing date -
Jan 30, 2002
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
Preferred embodiments of the current invention relate to methods of preventing and/or treating hearing loss by administration of L-carnitine or its derivatives. More particularly, administration of L-carnitine or its derivatives is disclosed for preventing and/or treating hearing loss caused to mothers and/or their offspring during the perinatal period by the ototoxic effects of chemotherapeutic agents, aminoglycoside antibiotics, as well as excess noise.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully